Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ovarian Neoplasms × disitamab vedotin × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Stomach Neoplasms 6 Uterine Cervical Neoplasms 2 Non-Muscle Invasive Bladder Neoplasms 2 Carcinoma, Transitional Cell 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Ovarian Neoplasms 1 Ovarian Cancer Recurrent 1 Metastatic HER2 Positive Gastroesophageal Junction Cancer 1 Lung Neoplasms 1 High-risk Non-muscle Invasive Bladder Cancer 1 HER2-positive Metastatic Breast Cancer 1 HER2-low Breast Cancer 1 Castration-resistant Prostate Cancer 1 Advanced Breast Cancer 1

Interventions

Bevacizumab 36 Paclitaxel 27 Carboplatin 23 pembrolizumab 21 Specimen Handling 15 olaparib 13 Cisplatin 11 niraparib 10 Magnetic Resonance Spectroscopy 10 Cyclophosphamide 10 Blood Specimen Collection 10 fludarabine 8 Fulvestrant 8 Drug Therapy 8 Biopsy 8 Taxes 6 liposomal doxorubicin 5 Topotecan 5 Gemcitabine 5 Fluorouracil 5 Doxorubicin 5 mirvetuximab soravtansine 4 cemiplimab 4 aldesleukin 4 abemaciclib 4 Surveys and Questionnaires 4 Oxaliplatin 4 Interleukin-2 4 Immunoglobulin G 4 Hyperthermic Intraperitoneal Chemotherapy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06540729 2025-07-08

DAB

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡